Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

23.80
Delayed Data
As of Sep 21
 +2.25 / +10.44%
Today’s Change
7.75
Today|||52-Week Range
27.29
+79.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues227.9M198.4M184.4M202.1M
 
 
 
 
 
Cost of Goods Sold96.3M103.8M90.2M96.7M
 
 
 
 
 
Depreciation And Amortization26.7M25.2M25.8M28.2M
 
 
 
 
 
 
Operating ExpensesGross Income104.9M69.4M68.5M77.2M
 
 
 
 
 
General Expenses73.6M70.4M69.9M80.8M
 
 
 
 
 
Research And Development20.1M20.5M22.5M26.8M
 
 
 
 
 
Total Operating Expenses196.5M199.4M185.8M205.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income31.4M-1.0M-1.4M-3.6M
 
 
 
 
 
Extraordinary Charge-304.0M-255.2M-52.2M-6.4M
 
 
 
 
 
Interest Expense On Debt11.1M13.6M13.4M13.4M
 
 
 
 
 
Other Expenses-373.0K-1.4M-687.0K2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-283.9M-271.0M-67.5M-20.9M
 
 
 
 
 
Income Taxes-104.5M-8.6M-30.9M-520.0K
 
 
 
 
 
Net Income-179.3M-279.6M-98.4M-20.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS71.3M71.5M71.6M71.8M
 
 
 
 
 
Shares To Calculate EPS Diluted71.3M71.5M71.6M71.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.51-$3.91-$1.37-$0.28
 
 
 
 
 
EPS Diluted-$2.51-$3.91-$1.37-$0.28